WASHINGTON, D.C. - Amgen Inc. has agreed to pay $24.9 million to resolve civil allegations that it paid kickbacks to three long-term care pharmacies to get them to induce nursing homes to give the Aranesp anemia drug to their patients, even if they didn't have anemia, the U.S. Justice Department announced April 16 (United States of America, ex rel. Frank Kurnik v. Amgen, Inc., et al., No. 3:11-1464, D. S.C.)....(read more)![]()
↧